Search company, investor...

Genezen Healthcare

genezenhealthcare.com

Stage

Convertible Note | Alive

Total Raised

$6.72M

Last Raised

$1.22M | 18 yrs ago

About Genezen Healthcare

Provider of services with physicians for in-office infusions of IV biologics. The company's services provide the staff and experience to pre-qualify a patient, provide the drug, schedule and administer the infusions, bill and collect for services, provide follow-up, and track outcomes.

Headquarters Location

15280 Addison Road Suite 250

Addison, Texas, 75001,

United States

(214)269-2350

Missing: Genezen Healthcare's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Genezen Healthcare's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Genezen Healthcare Frequently Asked Questions (FAQ)

  • Where is Genezen Healthcare's headquarters?

    Genezen Healthcare's headquarters is located at 15280 Addison Road, Addison.

  • What is Genezen Healthcare's latest funding round?

    Genezen Healthcare's latest funding round is Convertible Note.

  • How much did Genezen Healthcare raise?

    Genezen Healthcare raised a total of $6.72M.

  • Who are the investors of Genezen Healthcare?

    Investors of Genezen Healthcare include SightLine Partners and BPOC.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.